Science News
from research organizations

Reclaiming the immune system's assault on tumors

Date:
June 13, 2016
Source:
Ecole Polytechnique Fédérale de Lausanne
Summary:
One of the major obstacles with treating cancer is that tumors can conscript the body's immune cells and make them work for them. Researchers have now found a way to reclaim the corrupted immune cells, turn them into signals for the immune system to attack the tumor, and even prevent metastasis.
Share:
FULL STORY

A microscope photograph showing immune cells (green) attacking tumor cells (red).
Credit: Michele De Palma/EPFL

One of the major obstacles with treating cancer is that tumors can conscript the body's immune cells and make them work for them. Researchers at EPFL have now found a way to reclaim the corrupted immune cells, turn them into signals for the immune system to attack the tumor, and even prevent metastasis.

Macrophages are cells of the immune system that protect the host from invading pathogens. But in cancer, macrophages can be "hijacked" by tumors, and made to support their malignant growth and spread. This is a drawback for a major cancer treatment, immunotherapy, which turns the body's immune system against the tumor. EPFL scientists, working with colleagues at the Roche Innovation Centers in Munich and Basel, have now identified a molecular "switch" that can convert the "hijacked" macrophages into cells that can stimulate the immune system to fight the growth and spread of cancer. The work is published in Nature Cell Biology.

"Traitor" macrophages

Along with attacking foreign pathogens like bacteria, macrophages also help the body's organs develop and its wounds heal. Their own behavior is fine-tuned by small molecules that they produce, called microRNAs.

When a tumor begins to develop, macrophages attempt to block its growth. But often tumors hijack them and convert them into what are known as "tumor-associated macrophages," or TAMs for short.

Now corrupted, TAMs use their microRNAs to shield the tumor from the patient's immune system, helping it grow and metastasize. This phenomenon is common across many tumor types. It is one of the major obstacles in treating cancer, and often leads to a poor prognosis for the patient.

Reprogramming macrophages

Michele De Palma's team at EPFL found how to reclaim TAMs. The researchers genetically modified TAMs to remove their ability to produce microRNAs. As a result, the TAMs were reprogrammed dramatically. Instead of protecting the tumor, the TAMs now signaled the presence of the tumor to the immune system, triggering attacks against it -- and did so very efficiently.

Using a bioinformatics approach, the researchers found that the most likely culprit was a small family of microRNAs, called Let-7. This offers a more specific target: blocking Let-7 microRNAs may help instruct the TAMs to stimulate anti-tumor immunity.

Interestingly, the researchers observed that reprogramming TAMs also stops cancer cells from leaving the primary tumor. This could mean that the approach can also prevent tumor metastasis, the most threatening aspect of cancer. Moreover, the researchers found that the re-educated TAMs could enhance the anti-tumoral efficacy of certain cancer immunotherapies, some of which are already approved for patients.

However, more work is needed to translate all these findings to actual therapies, especially since there is currently no way to block the Let-7 microRNAs selectively in TAMs. But De Palma's lab is now working with bioengineers at EPFL to design drugs that can target the Let-7 microRNAs specifically in the TAMs.

Therapeutic opportunities

Some of the most promising cancer treatments are immunotherapies, which are based on provoking or enhancing the patient's immune response against their tumor. "The most exciting finding was that TAM reprogramming greatly improved the efficacy of immunotherapy," says Michele De Palma. "Our results in experimental models of cancer suggest a new therapeutic strategy based on inhibiting the microRNA machinery -- or the Let-7 microRNAs -- specifically in the TAMs, which may unleash the power of mainstream immunotherapies, such as immune checkpoint inhibitors."


Story Source:

Materials provided by Ecole Polytechnique Fédérale de Lausanne. Note: Content may be edited for style and length.


Journal Reference:

  1. Baer C, Squadrito ML, Laoui D, Thompson D, Hansen SK, Kiialainen A, Hoves S, Ries CH, Ooi C-H, De Palma M. Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumor immunity. Nat Cell Biol, June 2016 DOI: 10.1038/ncb3371

Cite This Page:

Ecole Polytechnique Fédérale de Lausanne. "Reclaiming the immune system's assault on tumors." ScienceDaily. ScienceDaily, 13 June 2016. <www.sciencedaily.com/releases/2016/06/160613122339.htm>.
Ecole Polytechnique Fédérale de Lausanne. (2016, June 13). Reclaiming the immune system's assault on tumors. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2016/06/160613122339.htm
Ecole Polytechnique Fédérale de Lausanne. "Reclaiming the immune system's assault on tumors." ScienceDaily. www.sciencedaily.com/releases/2016/06/160613122339.htm (accessed May 23, 2017).

RELATED STORIES